The device rapidly reduces the parasitaemia of severe Malaria patients who have been hospitalised and prescribed IV drug treatment.
While there are effective pharmaceutical treatments available, disease severity, recovery times and mortality are all strongly linked to a patient’s parasitaemia upon beginning drug treatment. Given the lengthy travel time required for many developing world patients to reach hospital many only get treatment once it’s too late. The key to tackling malaria lies in our ability to facilitate the rapid removal of infected red blood cells. When this is successfully carried out, a significant reduction of parasitaemia occurs – and that signifies the first steps on a patient's road to recovery.
Immune deficient patients
200k annual infant deaths
50% of the world at risk
Mortality rate 20%
Mosquito resistance to insecticides
Pre-clinical results appear to be very encouraging, indicating that the MediSieve Filter could reduce a child's parasitaemia by over 90% in two hours. Magnetic haemofiltration offers the chance to turn back the clock for these patients by rapidly and safely reducing a patient’s parasitaemia. A one-off treatment of a severe patient could reduce mortality, accelerate symptom reduction, and prevent disease escalation.
MediSieve expands its research into treating COVID-19
April 29, 2020
April 03, 2020